Regenn® Therapy System Safety Study

Clinical trial NCT06259409 · RECRUITING

Trial details

NCT number

NCT06259409

Sponsor

Progenerative Medical, Inc

Status

RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2024-10-09

Primary completion

2026-03-01

Enrollment

30

View on ClinicalTrials.gov